This article was originally published here
J Eur Acad Dermatol Venereol. 2021 Jul 26. doi: 10.1111/jdv.17542. Online ahead of print.
A 63-year-old Caucasian woman presented with rapidly developing lesions on both hands, elbows and feet, 9 days after she received the first dose of the Oxford-AstraZeneca COVID-19 vaccine ChAdOx1-S n-CoV19 (Vaxzevria®).